Advertisement
An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells (an approach known as CTL019) may cure some patients and prolong survival in others

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

0
T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.

Addition of Glitazone to Chemo May Help Treat CML

0
Combining glitazones with standard treatment improved survival in small study
Vietnam veterans exposed to Agent Orange have a more than doubled risk of developing monoclonal gammopathy of undetermined significance

Agent Orange Tied to MGUS in Vietnam Vets

0
Exposed veterans have higher rates of monoclonal gammopathy of undetermined significance
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
Older patients with acute myeloid leukemia are intense users of health care services and rarely use palliative care and hospice services

Older Cancer Patients Heavily Use Health Care Services

0
Regardless of chemo intensity, palliative care, hospice rarely used with acute myeloid leukemia
For patients with biochemically recurrent prostate cancer

Mushroom Powder Shows Potential in Prostate Cancer

0
Reduction in prostate-specific antigen level in some patients with biochemical recurrence
For elderly adults diagnosed with non-Hodgkin's lymphoma

Endoscopic Evaluation Advised in Non-Hodgkin’s Lymphoma

0
Report of elderly man with mantle cell lymphoma in addition to diffuse large B-cell lymphoma

August 2015 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for August 2015. This roundup includes...
The U.S. smoking rate continues to decline

CDC: Smoking Rate Falls to 15.2 Percent in the United States

0
Higher tobacco taxes, tough messages contributing to decline
For some pediatric cancer patients with relapsed or refractory cancer

Genomic Sequencing Benefits Some Childhood Cancer Patients

0
Benefits seen for some children and young adults with relapsed or refractory cancer